Thank you very much for the question, Mr. Thériault.
We've been in contact with a number of the manufacturing associations, and I believe that, as of yesterday, India has agreed to lift some of the restrictions on the export of the active pharmaceutical ingredients. We are hopeful that this will start the flow again, especially in combination with China coming back online. We still don't have a good timeline in terms of when the supplies are going to start flowing into Canada, but we are hopeful that it will pick up over the next coming weeks.
In terms of hydroxychloroquine, there is another drug, chloroquine, that can be used. Most of the focus has been on hydroxychloroquine, but they're both anti-malaria drugs and may have a similar effect. The supply for that will really depend on the ability of various companies around the world to supply the ingredients for hydroxychloroquine tablets to administer to patients.
We're definitely in a situation where there's an increased global demand for hydroxychloroquine and chloroquine as a result of all of the focus on COVID-19, and we do need all governments to encourage increased production of these medications for that reason alone. To date, the data are still somewhat questionable as to whether or not hydroxychloroquine has a clear benefit in COVID-19. Some of the research that has come out is promising, but it is not clearly showing that it has a major effect in improving the outcomes for people infected with COVID-19.